Skip to content
Review Open access

Efficacy and cosmetic outcomes of radiotherapy modalities in early-stage breast cancer: a systematic review and network meta-analysis

Sep 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 59 references
Medicine

TL;DR

Among patients with early-stage BC, HF-WBI was associated with the lowest rate of postoperative ipsilateral recurrence, whereas CF-WBI was associated with the second-lowest rate, and 3D-CRT and IMRT demonstrated favorable clinical efficacy and cosmetic outcomes.

Abstract

Breast cancer (BC) is a common malignancy with increasing annual incidence. Radiotherapy shows favorable clinical efficacy in BC management, but limited randomized controlled trial data is a major limitation. Therefore, further validation of the optimal radiotherapeutic strategy for early-stage BC is required. This network meta-analysis evaluated radiotherapy regimens’ effects on efficacy and cosmetic outcomes in early-stage BC, guiding clinical practice. A comprehensive literature search was conducted in PubMed, Cochrane Library, Embase, and Web of Science databases to identify randomized controlled trials and cohort studies investigating radiotherapy approaches for early-stage BC. Data screening and extraction were independently performed using a standardized protocol. Study quality was assessed using the Cochrane Risk of Bias tool and Newcastle–Ottawa Scale. The primary endpoint was ipsilateral breast recurrence (IBR), and secondary endpoints included locoregional recurrence, overall survival, disease-free survival, and cosmetic outcomes. Statistical analyses were performed using R 4.4.1 and STATA 18.0. A total of 36 studies involving 32,655 patients and 9 interventions were included. The lowest IBR rate was observed in patients treated with hypofractionated whole-breast irradiation (HF-WBI) (surface under the cumulative ranking curve [SUCRA], 10.54%), followed by conventional fractionated whole-breast irradiation (CF-WBI) (SUCRA, 35.70%). Compared with CF-WBI, intraoperative electron radiotherapy (IOeRT) (odds ratio [OR], 4.19; 95% credible interval [CrI], 1.83–10.26), intraoperative radiotherapy (IORT) (OR, 1.75; 95% CrI, 1.06–2.87), and HF-WBI (OR, 0.78; 95% CrI, 0.56–0.99) demonstrated statistically significant differences. The best cosmetic outcomes were achieved with three-dimensional conformal radiotherapy (3D-CRT) (SUCRA, 14.43%), followed by intensity-modulated radiotherapy (IMRT) (SUCRA, 16.04%). Compared with CF-WBI, 3D-CRT (OR, 0.11; 95% CrI, 0.01–0.85), IMRT (OR, 0.13; 95% CrI, 0.01–0.72), and IOeRT (OR, 0.25; 95% CrI, 0.04–0.78) showed statistically significant improvements. Since evidence supporting cosmetic outcomes is limited, findings should be interpreted with caution. Among patients with early-stage BC, HF-WBI was associated with the lowest rate of postoperative ipsilateral recurrence, whereas CF-WBI was associated with the second-lowest rate. In terms of cosmetic outcomes, 3D-CRT and IMRT demonstrated favorable clinical efficacy. Additional randomized controlled trials are necessary to clarify the comparative advantages and limitations of CF-WBI, HF-WBI, 3D-CRT, and IMRT, thereby strengthening the evidence base for early-stage BC radiotherapy strategies. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420251173161.

Read PDF

Similar papers

Review Open access Sep 2026

Effect of Surgical Delay After Neoadjuvant Chemotherapy on Survival Outcomes in Breast Cancer: A Systematic Review and Meta-Analysis

ABSTRACT Timely surgery after neoadjuvant chemotherapy (NAC) is essential in breast cancer management, yet delays remain common, particularly in low- and middle-income countries. Evidence on the impact of these delays is inconsistent. To evaluate the impact of time to surgery after NAC on survival outcomes in patients...

G. Gallego, Felicidad Claudia R. Ordoñez · 0 citations
Review Open access Sep 2026

Efficacy and safety of immune checkpoint inhibitors plus chemotherapy in early-stage triple-negative breast cancer: a systematic review and meta-analysis

Background Immune checkpoint inhibitors combined with chemotherapy have improved pathological responses in early-stage triple-negative breast cancer (TNBC), but the magnitude of benefit and associated toxicity remain variable across trials. This systematic review and meta-analysis aimed to evaluate the efficacy and saf...

Jia-Le Li, Pei-Tao Wu, Jing-Shu Song et al. · 0 citations
Review Open access Oct 2026

The preventive strategies for chronic persistent postsurgical pain following breast cancer surgery: A systematic review and meta-analysis

ABSTRACT Introduction: Breast cancer is the most common malignant disease among women worldwide. With improved treatment, 5-year survival has increased leading to increasing number of survivors reporting chronic persistent post-surgical pain (CPPP). Hence this systematic review and meta-analysis was conducted to analys...

Khushboo, Saxena Ashok Kumar, K. Rajeev et al. · 0 citations
Review Open access Aug 2026

Local excision of a residual tumor after neoadjuvant chemoradiotherapy for rectal cancer (a systematic review and meta-analysis of comparative studies)

B ACKGROUND: the optimal treatment strategy for patients with rectal cancer who achieve a complete or nearcomplete clinical response after neoadjuvant chemoradiotherapy is challenging. AIM: to assess oncological outcomes after neoadjuvant chemoradiotherapy followed by total mesorectumectomy (TME) or local ex...

V. V. Cherepahina, M. Alekseev, E. G. Rybakov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.